Prof. Lior Shapira is the Chairman of the Department of Periodontology and Vice Dean in the Hebrew University- Hadassah Faculty of Dental Medicine, Jerusalem. He is a Professor of Periodontology, and the Betty and D. Walter Cohen Chair in Clinical Periodontal Research. Prof. Shapira research is focused on the Host response during periodontal and peri-implant infections. He published over 100 scientific papers, as well as many reviews. Several international awards acknowledged the impact of his research work, including the Rizzo Award – IADR periodontal research group 1999, Finalist in the “Jaccard-EFP Research Price Competition” 2000, the Sunstar Award (Best article on perio-systemic connection) 2003 and the Distinguish Scientist Award in Periodontal Research – IADR 2009. Prof. Shapira is a Past-President of the Israeli Society, the Deputy-Chair of the Scientific Affairs Committee of the EFP and EFP Executive Committee member.
Click here for abstract:
The use of antibiotics in periodontitis - Specialist Panel
The use of antibiotics as an adjunct to mechanical debridement to treat periodontitis is known to be effective, but it remains controversial because of the wider context of the over-prescription of antibiotics and the rise of antimicrobial resistance (AMR). In May 2016, Dame Sally Davies, the chief medical officer for England, warned that the threat to humanity from AMR was on a par to that from terrorism and climate change, noting that there are already 50,000 deaths per year in Europe and the USA as the result of antibiotic-resistant infections. Moreover, according to World Health Organization, in the USA alone the calculated cost of hospitalisation because of AMR is up to $20 billion (€18 billion) per year. The consensus report of the sixth European Workshop in Periodontology in 2008 was that, in this context, antibiotics should be restricted for use with specific patient groups and conditions, such as in severe forms of periodontitis. Some clinicians have questioned the extent to which the use of antibiotics in periodontal therapy might contribute to the increase in antibiotic resistance. It is therefore still debatable how the potential added benefits of antibiotic use in periodontics rivals the potential hazards and increased costs stemming from AMR. Prof David Herrera and Prof Andrea Mombelli, will debate the issues.